Enhancing Pharmacology Education Through Collaborative Innovation: The Evolution and Future of PRORENATA at an Engineering-Based Medical Program.

IF 2.3 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Megan A Lim, Diamond Coleman, Noah Nigh, Chester Brown, Jessica Jia-Wen Saw, Noelle Kwan, Lisan Smith
{"title":"Enhancing Pharmacology Education Through Collaborative Innovation: The Evolution and Future of PRORENATA at an Engineering-Based Medical Program.","authors":"Megan A Lim, Diamond Coleman, Noah Nigh, Chester Brown, Jessica Jia-Wen Saw, Noelle Kwan, Lisan Smith","doi":"10.1002/prp2.70234","DOIUrl":null,"url":null,"abstract":"<p><p>Carle Illinois College of Medicine (CI MED), the first engineering-based medical program in the United States, approaches teaching medicine with an engineering innovation mindset. This approach is reflected in PRORENATA, a pioneering web application designed to address the challenge of incorporating longitudinal pharmacological concepts consistently throughout a curriculum. PRORENATA aims to alleviate resource burden and maximize the learning of pharmacologic concepts through concept mapping. A pilot version of PRORENATA was launched in 2023 and demonstrated general usability. This report shares the design and initial implementation of PRORENATA, a novel web-based medical educational resource to support medical student learning of pharmacology and its clinical applications. Following PRORENATA's pilot, a collaborative effort was established with MedTerms, another developing medical education resource, to further enhance PRORENATA. MedTerms, created by the National Center for Supercomputing Applications (NCSA) at the University of Illinois Urbana-Champaign, uses visualization design and an innovative software user interface buildout to facilitate learning of diseases from foundational principles. PRORENATA's distinguishing advantage is its foundational support by technical experts (designers, software engineers) and medical content experts (medical students, medical educators, medical specialists), ensuring content accuracy and relevance. Specifically, PRORENATA provides a visual organization of content in a tree-like structure, classifying content by class or disease states (e.g., hypertension, acute coronary syndrome, etc.). When the user clicks on specific drugs, more detailed information is revealed, including mechanism of action, key indication, common side effects, and contraindications. Each image within PRORENATA links to its source page. Ultimately, PRORENATA is a student-designed and created resource application to enhance pharmacology education.</p>","PeriodicalId":19948,"journal":{"name":"Pharmacology Research & Perspectives","volume":"14 2","pages":"e70234"},"PeriodicalIF":2.3000,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13140420/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pharmacology Research & Perspectives","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/prp2.70234","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Carle Illinois College of Medicine (CI MED), the first engineering-based medical program in the United States, approaches teaching medicine with an engineering innovation mindset. This approach is reflected in PRORENATA, a pioneering web application designed to address the challenge of incorporating longitudinal pharmacological concepts consistently throughout a curriculum. PRORENATA aims to alleviate resource burden and maximize the learning of pharmacologic concepts through concept mapping. A pilot version of PRORENATA was launched in 2023 and demonstrated general usability. This report shares the design and initial implementation of PRORENATA, a novel web-based medical educational resource to support medical student learning of pharmacology and its clinical applications. Following PRORENATA's pilot, a collaborative effort was established with MedTerms, another developing medical education resource, to further enhance PRORENATA. MedTerms, created by the National Center for Supercomputing Applications (NCSA) at the University of Illinois Urbana-Champaign, uses visualization design and an innovative software user interface buildout to facilitate learning of diseases from foundational principles. PRORENATA's distinguishing advantage is its foundational support by technical experts (designers, software engineers) and medical content experts (medical students, medical educators, medical specialists), ensuring content accuracy and relevance. Specifically, PRORENATA provides a visual organization of content in a tree-like structure, classifying content by class or disease states (e.g., hypertension, acute coronary syndrome, etc.). When the user clicks on specific drugs, more detailed information is revealed, including mechanism of action, key indication, common side effects, and contraindications. Each image within PRORENATA links to its source page. Ultimately, PRORENATA is a student-designed and created resource application to enhance pharmacology education.

通过协同创新加强药理学教育:PRORENATA在工程医学项目中的发展与未来。
卡尔伊利诺伊医学院(CI MED)是美国第一个以工程为基础的医学项目,以工程创新的思维方式来教授医学。这种方法反映在PRORENATA,一个开创性的网络应用程序,旨在解决在整个课程中始终如一地纳入纵向药理学概念的挑战。PRORENATA旨在通过概念映射减轻资源负担,最大限度地提高药理学概念的学习。PRORENATA的试验版本于2023年推出,并展示了一般可用性。本报告分享PRORENATA的设计和初步实施,PRORENATA是一种新型的基于网络的医学教育资源,用于支持医学生学习药理学及其临床应用。在PRORENATA试点之后,我们与另一家正在发展的医学教育资源MedTerms建立了合作关系,以进一步增强PRORENATA。MedTerms是由伊利诺伊大学厄巴纳-香槟分校的国家超级计算应用中心(NCSA)创建的,它使用可视化设计和创新的软件用户界面来促进从基本原理出发的疾病学习。PRORENATA的显著优势是由技术专家(设计师、软件工程师)和医学内容专家(医学生、医学教育者、医学专家)提供基础支持,确保内容的准确性和相关性。具体来说,PRORENATA以树状结构提供了内容的可视化组织,按类别或疾病状态(例如高血压、急性冠状动脉综合征等)对内容进行分类。当用户点击特定药物时,会显示更详细的信息,包括作用机制、关键适应症、常见副作用和禁忌症。PRORENATA中的每个图像都链接到其源页面。最终,PRORENATA是一个学生设计和创建的资源应用程序,以加强药理学教育。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Pharmacology Research & Perspectives
Pharmacology Research & Perspectives Pharmacology, Toxicology and Pharmaceutics-General Pharmacology, Toxicology and Pharmaceutics
CiteScore
5.30
自引率
3.80%
发文量
120
审稿时长
20 weeks
期刊介绍: PR&P is jointly published by the American Society for Pharmacology and Experimental Therapeutics (ASPET), the British Pharmacological Society (BPS), and Wiley. PR&P is a bi-monthly open access journal that publishes a range of article types, including: target validation (preclinical papers that show a hypothesis is incorrect or papers on drugs that have failed in early clinical development); drug discovery reviews (strategy, hypotheses, and data resulting in a successful therapeutic drug); frontiers in translational medicine (drug and target validation for an unmet therapeutic need); pharmacological hypotheses (reviews that are oriented to inform a novel hypothesis); and replication studies (work that refutes key findings [failed replication] and work that validates key findings). PR&P publishes papers submitted directly to the journal and those referred from the journals of ASPET and the BPS
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书